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ABSTRACT
The Open Regulatory Annotation database (ORegAnno) is a resource for curated regulatory annotation. It contains information about regulatory regions, transcription factor binding sites, RNA binding sites, regulatory variants, haplotypes, and other
regulatory elements. ORegAnno differentiates itself from other regulatory resources by facilitating
crowd-sourced interpretation and annotation of regulatory observations from the literature and highly curated resources. It contains a comprehensive annotation scheme that aims to describe both the elements
and outcomes of regulatory events. Moreover, ORegAnno assembles these disparate data sources and
annotations into a single, high quality catalogue of
curated regulatory information. The current release
is an update of the database previously featured in
the NAR Database Issue, and now contains 1 948 307
records, across 18 species, with a combined coverage of 334 215 080 bp. Complete records, annotation,
and other associated data are available for browsing
and download at http://www.oreganno.org/.
INTRODUCTION
The Open Regulatory Annotation database (ORegAnno)
was first released about a decade ago (1), with the intention to collect and synthesize a catalogue of regulatory ele-

ments. It remains unique in the field because of its focus on
collecting high quality, curated regulatory records from the
literature. Moreover, ORegAnno relies on a thriving community of scientists who are interested in contributing to the
resource, as well as utilizing its data. Since the last release of
ORegAnno in early 2008 (2), the amount and types of published regulatory data have grown exponentially. This relates in part to high-throughput studies from the ENCODE
consortium and others, who have performed an enormous
number of ChIP-seq, DNase-seq, FAIRE-seq and other experiments aiming to identify biochemically available and
transcriptionally active regions of genomes (3). While these
efforts are excellent resources for identifying candidate regulatory regions, ENCODE efforts have suggested that as
much as 80% of the genome could be functional (3). This
controversial finding has been the focus of much attention
in the community, with several commentaries pointing out
that these types of high-throughput data are prone to overestimates due to experimental and statistical methods that
result in a high number of false positive calls (4–6). Moreover, they do not necessarily provide a comprehensive understanding of all of the elements involved in gene regulation. For example, knowing the region of DNA that is
bound by a transcription factor does not directly indicate
whether the expression of any genes are altered, nor whether
an alteration results in up- versus down-regulation. Validation of the genomic regions identified by ENCODE and
others requires a large number of low-throughput experimental data paired with careful manual curation. Additionally, much of the available evidence supporting gene regu-
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lation is dispersed across various experiments, specialized
datasets, and individual publications, making it cumbersome to obtain regulatory information that has been released by the community across this broad set of sources.
The current version of ORegAnno seeks to address these
issues by cataloging a large number of new, curated, high
quality regulatory records that are derived from published
literature and other data resources.
RESULTS
Overview

Updates
Older records, including those that were added through
crowd-sourcing efforts via the web, have been updated to ensure that only accurate and up-to-date gene symbols are being used. This was accomplished through a combination of
automatically updating symbols using NCBI Gene or ENSEMBL identifiers, as well as by manually checking incorrect and missing data. In addition, previously missing identifiers from NCBI Gene or ENSEMBL have been added
where possible, allowing for future automated updates to
ensure the accuracy of these gene lists. These updates have
resulted in 423 automated changes and 13,174 manually curated changes (13 597 total) affecting 10 386 records.
For all ORegAnno records (existing and new), genomic
coordinates have been updated and expanded using liftOver
(27). This involved converting older genomic coordinates to
newer assembly versions, as well as converting coordinates
from new versions to older assemblies. Thus, each record
may now be associated with multiple genomic coordinates
(from multiple assembly versions). For example, since the
last version of ORegAnno was published in 2008, the human genome assembly version GRCh38/hg38 was released.
All existing ORegAnno human records having genomic
coordinates based on assembly versions GRCh36/hg18
or GRCh37/hg19 now have additional updated coordinates using GRCh38/hg38. Similarly, new records that
were entered using GRCh38/hg38 coordinates have received additional coordinates based on GRCh37/hg19 and
GRCh36/hg18. This allows users to access the genomic coordinates of regulatory regions for the assembly versions
that best suit their purposes. Finally, new types of transcriptional regulation have been defined in the current release
(Figure 1C and D). These includes microRNA and small
non-coding RNA binding sites, as well as operons that function to regulate multiple genes under a single promoter.
New records
ORegAnno has maintained a focus on incorporating
records derived from high quality, manually curated evidence for gene regulation. These typically include experimental evidence demonstrating that binding of a regulatory
element to a specific region of DNA or RNA alters corresponding gene expression levels. In total, the current release of ORegAnno contains 2010 unique records covering
112 582 bp derived directly through literature curation, including 661 records that have been added since the previous
ORegAnno release.
Highly validated external databases that had been incorporated into earlier ORegAnno releases have been updated.
This includes 1874 new records covering an additional 3
591 656 bp derived from VISTA Enhancers (28) (2196 total records covering 3 996 796 total bp), 2934 new records
covering an additional 863,201 bp derived from the Yeast
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The current version of ORegAnno now has a total of 1 948
307 unique records. These records cover a combined 334
215 080 bp across 18 species (Figure 1A and B). The vast
majority of these records are mapped to human and mouse
genomes, with 1 452 466 records in human (261 660 516
bp in the GRCh38/hg38 genome assembly version) and 415
808 records in mouse (57 253 973 bp in the GRCm38/mm10
genome assembly version).
As a measure of the success of our community-based participation, ORegAnno currently has 1044 registered users.
Aside from the principal authors of this paper, 13 301
records have been contributed by members of the broader
community (The Open Regulatory Annotation Consortium). ORegAnno continues to have a robust verification
system to ensure that contributed records are accurate and
appropriately annotated. A set of trusted consortium members have been granted a ‘validator’ status, allowing them
to review and up- or down-vote records. This results in individual record scores that are visible to all users. Moreover, when a record is negatively scored, it will typically be
assigned a deprecated status. ORegAnno additionally includes an ontology for summarizing the experimental evidence that supports the regulatory elements and outcome
in each record. Together, these features allow users to filter
records according to various quality criteria.
The ORegAnno database has served as a repository
for publishing regulatory sites derived from experimental
data (7), and it has been incorporated into other resources
including the Babelomics (8), cisRED (9), ConTra (10),
GRASP (11), i-cisTarget (12), LASAGNA-Search 2.0 (13),
the UCSC Genome Browser (14) and more. Similarly, the
annotated information included in ORegAnno has been
used to construct gene regulation networks for the development of other tools and the analysis of gene expression
data (15–19). ORegAnno records were used in the REC-set
design for a capture sequence reagent (20), and as part of the
definition for regulatory sites of the human genome (tier 2)
in the Genome Modeling System (21), an analysis information management system at the McDonnell Genome Institute of Washington University that has been used to process
over 4800 human whole genome samples, over 40 000 exomes, and over 1400 transcriptomes. Similarly, ORegAnno
has been adapted into the information systems of other research centers including the Broad Institute and Cancer Research UK, where it has been used in the analysis of several
high impact studies (22–25).
Because ORegAnno focuses on curated regulatory information, the total genomic coverage found in ORegAnno is
smaller than that identified by resources such as ENCODE

or the ENSEMBL regulatory tracks (26), which are largely
a summary of ENCODE data (Figure 2). This trade off
is part of an effort to ensure that ORegAnno represents a
high-quality curated set of regulatory elements, with the aim
of maintaining a low number of false positive records.
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Figure 1. Current content of the ORegAnno database. Content statistics are divided by species (A and B), regulatory type (C and D), and data source (E
and F).
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Data access
Figure 2. Comparison of the genomic coverage captured by ORegAnno
and the ENSEMBL Regulatory Track. A Venn diagram demonstrates coverage overlaps for human genome assembly version GRCh38/hg38, with
sets sized to scale. The ENSEMBL Regulatory Track is divided into two
main sets, a track overview set and the transcription factor binding site
(TFBS) set.

Regulatory Map (29) (7320 total records covering 899 449
total bp), as well as 2051 new transcription factor binding
site records covering an additional 29 405 bp derived from
REDfly (30) (2695 total records covering 913 486 total bp).
Previously, ORegAnno had imported records from FlyReg
(31), which has since been merged into REDfly.
New records have been created by importing data from
external databases that were not found in previous ORegAnno releases. This includes 1 093 443 records covering
11 780 604 bp imported from the JASPAR CORE database
(32), which contains a curated, non-redundant set of experimentally obtained transcription factor binding sites in
eukaryotes. 783 742 records covering 300 003 052 bp were
imported from the PAZAR database (33), which included
only records with curated evidence of transcription factor
binding and regulatory sequence annotation across various
species. 11 451 records covering 4 194 677 bp were derived
from RegulonDB (34), a database of transcriptional regulation in Escherichia coli K-12, and includes manually curated
records that have been complemented with high throughput datasets and comprehensive computational predictions.
We combined conserved miRNA target site predictions
from miRanda-mirSVR (35) with experimentally-validated
miRNA-target interaction data from miRTarBase (36),
leading to the addition of 3,072 new ORegAnno records
covering 44 353 bp. 131 records covering 1216 bp were derived from NFI-RegulomeDB (37), a database with curated
binding sites for the NFI (Nuclear Factor I) family of transcription factors using data from the published literature.
Finally, 51 transcription factor binding site records covering 7503 bp were created from the PCNE database of phylogenetically conserved noncoding elements (38).

The ORegAnno database continues to be accessible under
an open-source license (GNU Lesser General Public License), in order to encourage development and participation from the community. Monthly ORegAnno database
summaries are automatically performed and provide fundamental regulatory information from ORegAnno in a tabdelimited text file that is available for free download, without the need to register with the ORegAnno website (http:
//www.oreganno.org/).
The ORegAnno website back end code has been updated to improve security and performance, and to accommodate the new data types, dataset sources, and the increased number of records that have been added since the
previous release. New search functionality has been added,
including the ability to browse records by transcription
factor/regulatory element of interest. Source code for the
ORegAnno website is available at https://java.net/projects/
oreganno/.
The regulatory regions and associated annotation for
all supported species have been submitted to the UCSC
Genome Browser (14) as updates to existing ORegAnno
tracks. This updates existing tracks with a more comprehensive collection of putatively regulatory elements, and additionally provides new tracks on several genome assembly
versions.
Applications
Recently, there has been immense focus on the role of regulatory regions in cancer. In particular, recurrent somatic
mutations in the TERT promoter have been identified in
various cancer types (42–45), and are associated with increased expression of TERT. Although the importance of
TERT up-regulation in cancer has been well-established
for nearly two decades (46), it is only in recent years that
we’ve identified the regulatory mechanism driving TERT
up-regulation in such cases. While additional efforts have
identified a small number of other recurrent regulatory mutations in cancer (47–49), this number is far smaller than the
recurrent protein-coding mutations that have been identified. This is likely due to several factors, including that most
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Because of the open and accessible design of the ORegAnno database and website, ORegAnno has been used
for submitting published experimental data. Since the previous ORegAnno release, four datasets derived from high
throughput studies have been submitted, and were subsequently curated to ensure that only regulatory regions
with a high degree of evidence were retained. These include
RELA (p65) ChIP−PET binding sites in human monocytes
(39) (489 records covering 52 886 bp), ESR1 binding sites in
human MCF-7 breast cancer cells (40) (1234 records covering 165 538 bp), Esr1 binding sites in mouse liver (41) (5568
records covering 2 378 460 bp), and Foxa2 binding sites in
mouse liver (7) (11 475 records covering 8 236 933 bp). In
all of these cases, DNA sequences were filtered according to
signal strength and proximity to signal peak to reduce false
positive calls. A summary of the number of records and genomic coverage contributed by each data source is shown in
Figure 1E, F and Supplementary Table S1.
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Figure 3. Capture reagent using ORegAnno sites improves coverage of regulatory regions in human hepatocellular carcinoma. (A) Coverage across the
entire ‘regulome’ is visualized as a heatmap for each of the ten HCC cases. WRS samples have greater sequencing read depth across the targeted region,
compared with WGS samples. (B) An illustrative IGV (51) screenshot is shown of the TERT promoter for one HCC case. A canonical C228T somatic
mutation is observed in the WRS data, but cannot be reliably called in the WGS data.
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SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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